Zusammenfassung
Die Betrachtung der Ursachen abhängigen Verhaltens bei Personen mit einer Substanzabhängigkeit aus neurobiologischer Perspektive ist komplex. So sind allen stoffgebundenen Abhängigkeitserkrankungen einige klinische Merkmale gemeinsam.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Ait-Daoud N, Johnson BA, Prihoda TJ, Hargita ID (2001) Combining ondansetron and naltrexone reduces craving among biologically predisposed alcoholics: preliminary clinical evidence. Psychopharmacology (Berl) 154: 23–27
Akash KG, Balarama KS, Paulose CS (2008) Enhanced 5-HT(2A) receptor status in the hypothalamus and corpus striatum of ethanol-treated rats. Cell Mol Neurobiol 28: 1017–1025
Bechara A (2004) Disturbances of emotion regulation after focal brain lesions. Int Rev Neurobiol 62: 159–193
Beck A, Schlagenhauf F, Wustenberg T et al (2009) Ventral striatal activation during reward anticipation correlates with impulsivity in alcoholics. Biol Psychiatry 66: 734–742
Belujon P, Grace AA (2011) Hippocampus, amygdala, and stress: interacting systems that affect susceptibility to addiction. Ann NY Acad Sci 1216: 114–121
Benkert O, Hippius H (2011) Kompendium der Psychiatrischen Pharmakotherapie, 8. Aufl. Springer, Berlin, Heidelberg, New York
Berger SL (2007) The complex language of chromatin regulation during transcription. Nature 447: 407–412
Berger SP, Hall S, Mickalian JD et al (1996) Haloperidol antagonism of cueelicited cocaine craving. Lancet 347: 504–508
Bliss TV, Collingridge GL (1993) A synaptic model of memory: long-term potentiation in the hippocampus. Nature 361: 31–39
Blum K, Chen AL, Chen TJ et al (2008) Activation instead of blocking mesolimbic dopaminergic reward circuitry is a preferred modality in the long term treatment of reward deficiency syndrome (RDS): a commentary. Theor Biol Med Model 12(5): 24
Boning J (1992) Zur Neurobiologie und Phanomenologie eines »Suchtgedachtnisses«. Sucht 38: 105–106
Bowers MS, Chen BT, Chou JK et al (2007) Acamprosate attenuates cocaineand cue-induced reinstatement of cocaine-seeking behavior in rats. Psychopharmacology (Berl) 195: 397–406
Budde H, Sander T, Wernicke C et al (2010) Serotonin transporter promoter polymorphism and dopaminergic sensitivity in alcoholics. J Neural Transm 117: 133–138
Carboni E, Acquas E, Frau R, Di Chiara G (1989) Differential inhibitory effects of a 5-HT3 antagonist on drug-induced stimulation of dopamine release. Eur J Pharmacol 164: 515–519
Chua EF, Schacter DL, Sperling RA (2009) Neural correlates of metamemory: a comparison of feeling-of-knowing and retrospective confidence judgements. J Cogn Neurosci 21: 1751–1765
Craig AD (2009) How do you feel now? The anterior insula and human awareness; Nat Rev Neurosci 10: 59–70
Croissant B, Klein O, Gehrlein L et al (2006) Quetiapine in relapse prevention in alcoholics suffering from craving and affective symptoms: a case series. Eur Psychiatry 21: 570–573
Cowen MS, Lawrence AJ (1999) The role of opioid-dopamine interactions in the induction and maintenance of ethanol consumption. Prog Neuropsychopharmacol Biol Psychiatry 23: 1171–1212
Daglish MR, Williams TM, Wilson SJ et al (2008) Brain dopamine response in human opioid addiction. Br J Psychiatry 193: 65–72
Diana M, Muntoni AL, Pistis M et al (1999) Lasting reduction in mesolimbic dopamine neuronal activity after morphine withdrawal. Eur J Neurosci 11: 1037–1041
Dick DM, Foroud T (2003) Candidate genes for alcohol dependence: a review of genetic evidence from human studies. Alcohol Clin Exp Res 27: 868–879
Dick DM, Rose RJ, Viken RJ et al (2001) Exploring gene-environment interactions: socioregional moderation of alcohol use. J Abnorm Psychol 110: 625–632
Edwards G (1990) Withdrawal symptoms and alcohol dependence: fruitful mysteries. Br J Addict 85: 447–461
Feltenstein MW, Do PH, See RE (2009) Repeated aripiprazole administration attenuates cocaine seeking in a rat model of relapse. Psychopharmacology (Berl) 207: 401–411
Fils-Aime ML, Eckardt MJ, George DT et al (1996) Early-onset alcoholics have lower cerebrospinal fluid 5-hydroxyindoleacetic acid levels than lateonset alcoholics. Arch Gen Psychiatry 53: 211–216
Fiorillo CD, Newsome WT, Schultz W (2008) The temporal precision of reward prediction in dopamine neurons. Nat Neurosci 11: 966–973
Flagel SB, Clark JJ, Robinson TE et al (2011) A selective role for dopamine in stimulus-reward learning. Nature 469: 53–57
Gao C, Che LW, Chen J et al (2003) Ohmefentanyl stereoisomers induce changes of CREB phosphorylation in hippocampus of mice in conditioned place preference paradigm. Cell Res 13: 29–34
Garavan H, Stout JC (2005) Neurocognitive insights into substance abuse. Trends Cogn Sci 9: 195–201
George DT, Rawlings R, Eckardt MJ et al (1998) Buspirone treatment of alcoholism: age of onset, and cerebrospinal fluid 5-hydroxyindolacetic acid and homovanillic acid concentrations, but not medication treatment, predict return to drinking. Alcohol Clin Exp Res 23: 272–278
Gianoulakis C (2004) Endogenous opioids and addiction to alcohol and other drugs of abuse. Curr Top Med Chem 4: 39–50
Goldstein RZ, Alia-Klein N, Tomasi D et al (2009a) Anterior cingulate cortex hypoactivations to an emotionally salient task in cocaine addiction. Proc Natl Acad Sci USA 106: 9453–9458
Goldstein RZ, Craig AD, Bechara A et al (2009b) The neurocircuitry of impaired insight in drug addiction. Trends Cogn Sci 13: 372–380
Grusser SM, Wrase J, Klein S et al (2004) Cue-induced activation of the striatum and medial prefrontal cortex is associated with subsequent relapse in abstinent alcoholics. Psychopharmacology (Berl) 175: 296–302
Hebb DO (1949) The organization of behaviour. Wiley, New York
Heinz A (2000) Das dopaminerge Verstarkungssystem: Funktion, Interaktion mit anderen Neurotransmittersystemen und psychopathologische Korrelate. Steinkopff, Darmstadt
Heinz A., Batra A (2003) Neurobiologie der Alkohol und Nikotinabhangigkeit. In: Brandt, Cohen, Helmchen, Schmidt (Hrsg) Psychiatrie, Neurologie, Klinische Psychologie. Kohlhammer, Stuttgart
Heinz A, Lichtenberg-Kraag B, Sällström Baum S et al (1995) Evidence for prolonged recovery of dopaminergic transmission in alcoholics with poor treatment outcome. J Neural Transm 102: 149–158
Heinz A, Dufeu P, Kuhn S et al (1996) Psychopathological and behavioral correlates of dopaminergic sensitivity in alcohol-dependent patients. Arch Gen Psychiatry 53: 1123–1128
Heinz A, Siessmeier T, Wrase J et al (2004) Correlation between dopamine D2 receptors in the ventral striatum and central processing of alcohol cues and craving. Am J Psychiatry 161: 1783–1789
Heinz A, Beck A, Grusser SM, Grace AA, Wrase J (2009a) Identifying the neural circuitry of alcohol craving and relapse vulnerability. Addict Biol 14: 108–18
Heinz A, Beck A, Wrase J et al (2009b) Neurotransmitter systems in alcohol dependence. Pharmacopsychiatry 42(Suppl 1): S95-S101
Hester R, Nestor L, Garavan H (2009) Impaired error awareness and anterior cingulate cortex hypoactivity in chronic cannabis users. Neuropsychopharmacology 34: 2450–2458
Hommer DW, Bjork JM, Gilman JM (2011) Imaging brain response to reward in addictive disorders. Ann NY Acad Sci 1216: 50–61
Ivanov A, Aston-Jones G (2001) Local opiate withdrawal in locus coeruleus neurons in vitro. J Neurophysiol 85: 2388–2397
Jackson ME, Moghaddam B (2001) Amygdala regulation of nucleus accumbens dopamine output is governed by the prefrontal cortex. J Neurosci 21: 676–681
Jaenisch R, Bird A (2003) Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet 33(Suppl): 245–254
Kiefer F, Mann K (2010) Acamprosate: how, where, and for whom does it work? Mechanism of action, treatment targets, and individualized therapy. Curr Pharm Des 16: 2098–2102
Kiefer F, Jahn H, Tarnaske T et al (2003) Comparing and combining naltrexone and acamprosate in relapse prevention of alcoholism: a doubleblind, placebo-controlled study. Arch Gen Psychiatry 60: 92–99
Kienast T, Wrase J, Heinz A (2008) Neurobiology of substance-related addiction: findings of neuroimaging. Fortschr Neurol Psychiatr 76(Suppl 1): S68–76
Kim M, Au E, Neve R, Yoon BJ (2009) AMPA receptor trafficking in the dorsal striatum is critical for behavioral sensitization to cocaine in juvenile mice. Biochem Biophys Res Commun 379(1): 65–69
Konorski J (1948) Conditioned reflexes and neuron organisation. Cambridge University Press, Cambridge
Koob G F, Le Moal M (1997) Drug abuse: hedonic homeostatic dysregulation. Science 278: 52–58
Koob GF, Volkow ND (2010) Neurocircuitry of addiction. Neuropsychopharmacology 35: 217–238
Kranzler HR, Pierucci-Lagha A, Feinn R, Hernandez-Avila C (2003) Effects of ondansetron in early- versus late-onset alcoholics: a prospective, openlabel study. Alcohol Clin Exp Res 27: 1150–1155
Kullmann DM, Lamsa KP (2011) LTP and LTD in cortical GABAergic interneurons: emerging rules and roles. Neuropharmacology 60(5): 712–719
Kumar S, Porcu P, Werner DF et al (2009) The role of GABA(A) receptors in the acute and chronic effects of ethanol: a decade of progress. Psychopharmacology (Berl) 205: 529–564
Land BB, Bruchas MR, Schattauer S et al (2009) Activation of the kappa opioid receptor in the dorsal raphe nucleus mediates the aversive effects of stress and reinstates drug seeking. Proc Natl Acad Sci USA 106: 19168–19173
Lee BR, Dong Y (2011) Cocaine-induced metaplasticity in the nucleus accumbens: Silent synapse and beyond. Neuropharmacology 61(7): 1060–1069
Lee AM, Messing RO (2008) Protein kinases and addiction. Ann NY Acad Sci 1141: 22–57
Lin Z, Uhl GR (2002) Dopamine transporter mutants with cocaine resistance and normal dopamine uptake provide targets for cocaine antagonism. Mol Pharmacol 61: 885–891
Lisman J, Morris RG (2001) Memory. Why is the cortex a slow learner? Nature 411: 248–249
Maldonado R, Salardi A, Valverde O et al (1997) Absence of opiate rewarding effects in mice lacking dopamine D2 receptors. Nature 388: 586–589
Mayer EA, Naliboff B, Munakata J (2000) The evolving neurobiology of gut feelings. Prog Brain Res 122: 195–206
Maze I, Nestler EJ (2011) The epigenetic landscape of addiction. Ann NY Acad Sci 1216: 99–113
Mihic SJ, Ye Q, Wick MJ et al (1997) Sites of alcohol and volatile anaesthetic action on GABA(A) and glycine receptors. Nature 389: 385–389
Moron JA, Gullapalli S, Taylor C et al (2010) Modulation of opiate-related signaling molecules in morphine-dependent conditioned behavior: conditioned place preference to morphine induces CREB phosphorylation. Neuropsychopharmacology 35: 955–966
Moussawi K, Pacchioni A, Moran M et al (2009) N-Acetylcysteine reverses cocaine-induced metaplasticity. Nat Neurosci 12: 182–189
Moussawi K, Zhou W, Shen H et al (2010) Reversing cocaine-induced synaptic potentiation provides enduring protection from relapse. Proc Natl Acad Sci USA 108: 385–390
Muller DJ, Likhodi O, Heinz A (2010) Neural markers of genetic vulnerability to drug addiction. Curr Top Behav Neurosci 3: 277–299
Nader MA, Morgan D, Gage HD et al (2006) PET imaging of dopamine D2 receptors during chronic cocaine self-administration in monkeys. Nat Neurosci 9: 1050–1956
Nestler EJ (2001) Molecular basis of long-term plasticity underlying addiction. Nat Rev Neurosci 2: 119–128
Nestler EJ, Aghajanian GK (1997) Molecular and cellular basis of addiction. Science 278: 58–63
Noble F, Cox BM (1996) Differential desensitization of μ- and δ-opioid receptors in selected neural pathways following chronic morphine treatment. Br J Pharmacol 117: 161–169
O’Brien CP, Terenius LY, Nyberg N et al (1988) Endogenous opioids in the cerebrospinal fluid of opiate-dependent humans. Biol Psychiatr 24: 649–662
Paulus MP, Tapert SF, Schuckit MA (2005) Neural activation patterns of methamphetamine-dependent subjects during decision making predict relapse. Arch Gen Psychiatry 62: 761–768
Perez MF, Ford KA, Goussakov I et al (2011) Repeated cocaine exposure decreases dopamine D2-like receptor modulation of Ca(2+) homeostasis in rat nucleus accumbens neurons. Synapse 65: 168–180
Perreau-Lenz S, Sanchis-Segura C, Leonardi-Essmann F et al (2010) Development of morphine-induced tolerance and withdrawal: involvement of the clock gene mPer2. Eur Neuropsychopharmacol 20: 509–517
Ridderinkhof KR, Ullsperger M, Crone EA, Nieuwenhuis S (2004) The role of the medial frontal cortex in cognitive control. Science 306: 443–447
Rocha BA, Fumagalli F, Gainetdinov RR et al (1998) Cocaine self-administration in dopamine-transporter knockout mice. Nature Neurosci 1: 132–137
Rosner S, Hackl-Herrwerth A, Leucht S et al (2010a) Acamprosate for alcohol dependence. Cochrane Database Syst Rev 9: CD004332
Rosner S, Hackl-Herrwerth A, Leucht S et al (2010b) Opioid antagonists for alcohol dependence. Cochrane Database Syst Rev 12: CD001867
Saal D, Dong Y, Bonci A, Malenka RC (2003) Drugs of abuse and stress trigger a common synaptic adaptation in dopamine neurons. Neuron 37: 577–582
Seeley WW, Allman JM, Carlin DA et al (2007) Divergent social functioning in behavioral variant frontotemporal dementia and Alzheimer disease: reciprocal networks and neuronal evolution. Alzheimer Dis Assoc Disord 21: S50–57
Self D (2003) Neurobiology: dopamine as chicken and egg. Nature 422: 573–574
Shaham Y, Hope BT (2005) The role of neuroadaptations in relapse to drug seeking. Nat Neurosci 8: 1437–1439
Siegel S (1983) Classical conditioning, drug tolerance and drug dependence. In: Israel I, Glaser FB, Kalant H et al (eds) Research advances in alcohol and drug problems. Plenum Press, New York, pp 207–246
Spanagel R, Sillaber I, Zieglgänsberger W et al (1998) Acamprosate suppresses the expression of morphine-induced sensitization in rats but does not affect heroin self-administration or relapse induced by heroin or stress. Psychopharmacology 139: 391–401
Tiihonen J, Vilkman H, Rasanen P et al (1998) Striatal presynaptic dopamine function in type 1 alcoholics measured with positron emission tomography. Mol Psychiatry 3: 156–161
Umhau JC, Momenan R, Schwandt ML et al (2010) Effect of acamprosate on magnetic resonance spectroscopy measures of central glutamate in detoxified alcohol-dependent individuals: a randomized controlled experimental medicine study. Arch Gen Psychiatry 67: 1069–1077
Vanderschuren LJ, Pierce RC (2010) Sensitization processes in drug addiction. Curr Top Behav Neurosci 3: 179–195
Vengeliene V, Bilbao A, Molander A, Spanagel R (2008) Neuropharmacology of alcohol addiction. Br J Pharmacol 154: 299–315
Verheul R, Van Den Brink W, Geerlings P (1999) A three-pathway psychobiological model of craving for alcohol. Alcohol Alcohol 34: 197–222
Vigano D, Rubino T, Di Chiara G et al (2003) Mu opioid receptor signaling in morphine sensitization. Neuroscience 117: 921–929
Volkow ND, Wang GJ, Fowler JS et al (1997) Decreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects. Nature 386: 830–833
Volpicelli JR, Alterman AI, Hayashida M, O’Brien CP (1992) Naltrexone in the treatment of alcohol dependence. Arch Gen Psychiatry 49: 876–880
Volpicelli JR, Watson NT, King AC et al (1995) Effect of naltrexone on alcohol »high« in alcoholics. Am J Psychiatry 152: 613–615
Vorel SR, Liu X, Hayes RJ, Spector JA, Gardner EL (2001) Relapse to cocaineseeking after hippocampal theta burst stimulation. Science 292: 1175–1178
Walters CL, Kuo YC, Blendy JA (2003) Differential distribution of CREB in the mesolimbic dopamine reward pathway. J Neurochem 87: 1237–1244
Wang GJ, Volkow ND, Fowler JS et al (1997) Dopamine D2 receptor availability in opiate-dependent subjects before and after naloxone-precipitated withdrawal. Neuropsychopharmacology 16: 174–182
Wiesbeck GA, Weijers HG, Lesch OM et al (2001) Flupentixol decanoate and relapse prevention in alcoholics: results from a placebo-controlled study. Alc Alcoholism 36: 329–334
Wikler A (1948) Recent progress in research on the neurophysiological basis of morphin addiction. Am J Psychiatry 105: 329–338
Willuhn I, Wanat MJ, Clark JJ, Phillips PE (2010) Dopamine signaling in the nucleus accumbens of animals self-administering drugs of abuse. Curr Top Behav Neurosci 3: 29–71
Wise RA (1982) Neuroleptics and operant behavior: the anhedonia hypothesis. Behav Brain Sci 5: 39–87
Wise RA (2008) Dopamine and reward: the anhedonia hypothesis 30 years on. Neurotox Res 14: 169–183
Wolffe AP, Matzke MA (1999) Epigenetics: regulation through repression. Science 286: 481–486
Xiao C, Zhang J, Krnjević K, Ye JH (2007) Effects of ethanol on midbrain neurons: role of opioid receptors. Alcohol Clin Exp Res 31: 1106–1113
Yi Wong CC, Mill J, Fernandes C (2011) Drugs and addiction: an introduction to epigenetics. Addiction 106(3): 480–489
Zaniewska M, McCreary AC, Wydra K, Filip M (2010) Differential effects of serotonin (5-HT)2 receptor-targeting ligands on locomotor responses to nicotine-repeated treatment. Synapse 64: 511–519
Zhang J, Xu M (2006) Opposite regulation of cocaine-induced intracellular signaling and gene expression by dopamine D1 and D3 receptors. Ann NY Acad Sci 1074: 1–12
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Kienast, T., Heinz, A. (2012). Abhängiges Verhalten bei Suchterkrankungen. In: Gründer, G., Benkert, O. (eds) Handbuch der psychiatrischen Pharmakotherapie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-19844-1_29
Download citation
DOI: https://doi.org/10.1007/978-3-642-19844-1_29
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-19843-4
Online ISBN: 978-3-642-19844-1
eBook Packages: Medicine (German Language)